About the Post-Conference Report
- Our TPD analyst team have screened the data from ASH 2022 and have identified 203 abstracts (165 clinical and 38 preclinical) associated with trial or drug records on Beacon TPD.
- This post-conference report provides an analysis of the abstracts, assessed by drug, trial phase, trial status, therapeutic class, target, and disease indication, followed by top-level summaries of the abstracts and trial outlines with links to their corresponding drug or trial page on the Beacon platform.
About Beacon Targeted Therapies
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements